Coca-Cola posted a 10 percent increase in fourth-quarter revenue to $9.5 billion, boosted by its $5.6 billion acquisition of sports performance and hydration drinks, BodyArmor.
The soda company’s hydration, sports, coffee, and tea segment grew 12 percent for the quarter, with sports drinks growing 18 percent.
According to Coke, BodyArmor was the No. 2 sports drink in the US in 2021 based on measured retail channels.
Coke acquired the remaining 85 percent shares of BodyArmor that it didn’t own in November.
BodyArmor will be managed as a separate business within Coca-Cola’s North America operating unit.
In 2021, Coke’s revenue soared 17 percent to $38.7 billion, with operating income dropping l 15 percent due to the “timing of concentrate shipments.”
Coca-Cola expects organic revenue growth of 7 to 8 percent in 2022 and commodity price inflation to be in the “mid-single-digit percentage.”
Meanwhile, Coca-Cola’s rival Pepsi recorded a fourth-quarter revenue of $25.25 billion, beating analysts’ estimates of $24.24 billion. It expects a 6 percent revenue growth in 2022.
Pepsi CEO Ramon Laguarta revealed that they expanded production capacity for its Gatorade sports drink, reportedly hit by supply chain issues related to bottle supply.
Both Coke and Pepsi attributed some of their revenue success to price hikes.


Enflame Shares Surge 200% in Shanghai AI Chip Debut
Anthropic Drops $6 Billion Decart AI Acquisition Talks
Qualcomm Stock Jumps on Amazon AI Chip Deal
White House Weighs Refined Copper Tariffs as Cost Concerns Grow
Brazil Court Suspends Sigma Lithium Mine Operations
Brent Oil Tops $100 as Middle East Conflict Threatens Supply
Huawei, Chinese AI Chipmakers Raise Prices as HBM Shortage Bites
OpenAI Agents Used Websites for Unauthorized Communications
Japanese Yen Nears Seven-Month High as Oil Approaches $100
Treasury Buyback Fails to Cool Long-Term Yields
BOJ Set to Raise Rates to 1.25% as Inflation Risks Build
Norway Core Inflation Rises to 3% in August
U.S. Stock Futures Steady as Oil Tops $100 Ahead of Inflation Data
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Kioxia Rules Out SK Hynix Manufacturing Partnership
Gold Prices Steady Ahead of U.S. Inflation Data and Fed Decision
Elon Musk’s Boring Company Raises $3 Billion at $23 Billion Valuation 



